1. Use of Factory-Calibrated Real-time Continuous Glucose Monitoring Improves Time in Target and HbA
- Author
-
Hood, Thabit, Joshi Navis, Prabhu, Womba, Mubita, Catherine, Fullwood, Shazli, Azmi, Andrea, Urwin, Ian, Doughty, and Lalantha, Leelarathna
- Subjects
Adult ,Blood Glucose ,Glycated Hemoglobin ,Male ,Cross-Over Studies ,Time Factors ,Adolescent ,Blood Glucose Self-Monitoring ,Glycemic Control ,Patient Care Planning ,United Kingdom ,Cohort Studies ,Young Adult ,Diabetes Mellitus, Type 1 ,Insulin Infusion Systems ,Computer Systems ,Calibration ,Humans ,Insulin ,Female - Abstract
International type 1 diabetes registries have shown that HbAWe conducted a randomized crossover trial in young people with type 1 diabetes (16-24 years old) comparing the Dexcom G6 CGM system and self-monitoring of blood glucose (SMBG). Participants were assigned to the interventions in random order during two 8-week study periods. During SMBG, blinded continuous glucose monitoring (CGM) was worn by each participant for 10 days at the start, week 4, and week 7 of the control period. HbATime in range was significantly higher during CGM compared with control (35.7 ± 13.5% vs. 24.6 ± 9.3%; mean difference 11.1% [95% CI 7.0-15.2];CGM use in young people with type 1 diabetes improves time in target and HbA
- Published
- 2020